Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 2 |
GO:0005737 | cytoplasm | 2 | 2 |
GO:0005930 | axoneme | 2 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4QBE2
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 145 | 149 | PF00656 | 0.595 |
CLV_C14_Caspase3-7 | 184 | 188 | PF00656 | 0.729 |
CLV_NRD_NRD_1 | 176 | 178 | PF00675 | 0.718 |
CLV_NRD_NRD_1 | 243 | 245 | PF00675 | 0.525 |
CLV_NRD_NRD_1 | 44 | 46 | PF00675 | 0.620 |
CLV_PCSK_KEX2_1 | 156 | 158 | PF00082 | 0.566 |
CLV_PCSK_KEX2_1 | 176 | 178 | PF00082 | 0.718 |
CLV_PCSK_KEX2_1 | 243 | 245 | PF00082 | 0.525 |
CLV_PCSK_KEX2_1 | 44 | 46 | PF00082 | 0.622 |
CLV_PCSK_PC1ET2_1 | 156 | 158 | PF00082 | 0.566 |
CLV_PCSK_SKI1_1 | 237 | 241 | PF00082 | 0.356 |
DOC_CKS1_1 | 197 | 202 | PF01111 | 0.614 |
DOC_CKS1_1 | 5 | 10 | PF01111 | 0.663 |
DOC_CYCLIN_yCln2_LP_2 | 261 | 267 | PF00134 | 0.415 |
DOC_CYCLIN_yCln2_LP_2 | 5 | 11 | PF00134 | 0.664 |
DOC_MAPK_DCC_7 | 218 | 226 | PF00069 | 0.567 |
DOC_MAPK_MEF2A_6 | 218 | 226 | PF00069 | 0.567 |
DOC_PP2B_LxvP_1 | 74 | 77 | PF13499 | 0.451 |
DOC_PP2B_LxvP_1 | 90 | 93 | PF13499 | 0.639 |
DOC_USP7_MATH_1 | 104 | 108 | PF00917 | 0.688 |
DOC_USP7_MATH_1 | 112 | 116 | PF00917 | 0.423 |
DOC_USP7_MATH_1 | 142 | 146 | PF00917 | 0.547 |
DOC_USP7_MATH_1 | 150 | 154 | PF00917 | 0.505 |
DOC_USP7_MATH_1 | 64 | 68 | PF00917 | 0.462 |
DOC_USP7_UBL2_3 | 152 | 156 | PF12436 | 0.558 |
DOC_WW_Pin1_4 | 196 | 201 | PF00397 | 0.638 |
DOC_WW_Pin1_4 | 211 | 216 | PF00397 | 0.471 |
DOC_WW_Pin1_4 | 4 | 9 | PF00397 | 0.663 |
DOC_WW_Pin1_4 | 88 | 93 | PF00397 | 0.687 |
LIG_14-3-3_CanoR_1 | 14 | 20 | PF00244 | 0.716 |
LIG_14-3-3_CanoR_1 | 218 | 222 | PF00244 | 0.566 |
LIG_14-3-3_CanoR_1 | 44 | 50 | PF00244 | 0.665 |
LIG_Actin_WH2_2 | 128 | 143 | PF00022 | 0.498 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.667 |
LIG_eIF4E_1 | 234 | 240 | PF01652 | 0.606 |
LIG_FHA_1 | 208 | 214 | PF00498 | 0.456 |
LIG_FHA_2 | 129 | 135 | PF00498 | 0.398 |
LIG_FHA_2 | 57 | 63 | PF00498 | 0.547 |
LIG_Integrin_RGD_1 | 244 | 246 | PF01839 | 0.573 |
LIG_LIR_Apic_2 | 194 | 200 | PF02991 | 0.664 |
LIG_LIR_Apic_2 | 252 | 258 | PF02991 | 0.561 |
LIG_LIR_Gen_1 | 67 | 77 | PF02991 | 0.491 |
LIG_LIR_Nem_3 | 67 | 72 | PF02991 | 0.483 |
LIG_NRP_CendR_1 | 271 | 273 | PF00754 | 0.523 |
LIG_SH2_CRK | 197 | 201 | PF00017 | 0.601 |
LIG_SH2_CRK | 69 | 73 | PF00017 | 0.504 |
LIG_SH2_NCK_1 | 255 | 259 | PF00017 | 0.535 |
LIG_SH2_STAT5 | 69 | 72 | PF00017 | 0.475 |
LIG_SH3_3 | 5 | 11 | PF00018 | 0.734 |
MOD_CDK_SPxxK_3 | 196 | 203 | PF00069 | 0.610 |
MOD_CDK_SPxxK_3 | 211 | 218 | PF00069 | 0.549 |
MOD_CDK_SPxxK_3 | 7 | 14 | PF00069 | 0.630 |
MOD_CK1_1 | 107 | 113 | PF00069 | 0.715 |
MOD_CK1_1 | 12 | 18 | PF00069 | 0.715 |
MOD_CK2_1 | 112 | 118 | PF00069 | 0.704 |
MOD_CK2_1 | 128 | 134 | PF00069 | 0.383 |
MOD_Cter_Amidation | 174 | 177 | PF01082 | 0.651 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.753 |
MOD_GlcNHglycan | 114 | 117 | PF01048 | 0.684 |
MOD_GlcNHglycan | 15 | 18 | PF01048 | 0.581 |
MOD_GlcNHglycan | 170 | 173 | PF01048 | 0.758 |
MOD_GlcNHglycan | 28 | 31 | PF01048 | 0.574 |
MOD_GSK3_1 | 104 | 111 | PF00069 | 0.744 |
MOD_GSK3_1 | 164 | 171 | PF00069 | 0.692 |
MOD_GSK3_1 | 207 | 214 | PF00069 | 0.504 |
MOD_GSK3_1 | 265 | 272 | PF00069 | 0.508 |
MOD_GSK3_1 | 3 | 10 | PF00069 | 0.745 |
MOD_GSK3_1 | 64 | 71 | PF00069 | 0.478 |
MOD_GSK3_1 | 75 | 82 | PF00069 | 0.520 |
MOD_NEK2_1 | 108 | 113 | PF00069 | 0.704 |
MOD_NEK2_1 | 209 | 214 | PF00069 | 0.487 |
MOD_PIKK_1 | 79 | 85 | PF00454 | 0.707 |
MOD_PKA_2 | 13 | 19 | PF00069 | 0.638 |
MOD_PKA_2 | 217 | 223 | PF00069 | 0.580 |
MOD_PKA_2 | 43 | 49 | PF00069 | 0.677 |
MOD_Plk_1 | 128 | 134 | PF00069 | 0.497 |
MOD_Plk_4 | 128 | 134 | PF00069 | 0.433 |
MOD_Plk_4 | 217 | 223 | PF00069 | 0.492 |
MOD_Plk_4 | 68 | 74 | PF00069 | 0.497 |
MOD_ProDKin_1 | 196 | 202 | PF00069 | 0.623 |
MOD_ProDKin_1 | 211 | 217 | PF00069 | 0.469 |
MOD_ProDKin_1 | 4 | 10 | PF00069 | 0.663 |
MOD_ProDKin_1 | 88 | 94 | PF00069 | 0.686 |
MOD_SUMO_rev_2 | 148 | 158 | PF00179 | 0.546 |
TRG_ENDOCYTIC_2 | 69 | 72 | PF00928 | 0.518 |
TRG_ER_diArg_1 | 242 | 244 | PF00400 | 0.526 |
TRG_ER_diArg_1 | 43 | 45 | PF00400 | 0.576 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I2Y3 | Leptomonas seymouri | 51% | 93% |
A0A1X0NXL5 | Trypanosomatidae | 34% | 100% |
A0A3Q8ICG3 | Leishmania donovani | 94% | 100% |
A0A422NW27 | Trypanosoma rangeli | 25% | 100% |
A4HCP6 | Leishmania braziliensis | 76% | 100% |
A4I072 | Leishmania infantum | 94% | 100% |
C9ZUY6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 30% | 100% |
E9AW35 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 87% | 100% |